Abstract
Background: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. Objective: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. Methods: The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. Results: For fiscal years 2016 and 2017, the program provided an average return of $US1.46–2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. Conclusion: A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment.
Cite
CITATION STYLE
Orsak, G., Miller, A., Allen, C. M., Singh, K. P., & McGaha, P. (2020). Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas. PharmacoEconomics - Open, 4(1), 71–77. https://doi.org/10.1007/s41669-019-0147-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.